A detailed history of Concentric Capital Strategies, LP transactions in Danaher Corp stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 2,367 shares of DHR stock, worth $574,754. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,367
Previous 8,836 73.21%
Holding current value
$574,754
Previous $2.21 Million 73.21%
% of portfolio
0.03%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $1.52 Million - $1.73 Million
-6,469 Reduced 73.21%
2,367 $591,000
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $1.98 Million - $2.26 Million
8,836 New
8,836 $2.21 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $3.41 Million - $3.88 Million
14,624 New
14,624 $3.63 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $687,619 - $869,014
-2,900 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $746,083 - $915,704
2,900 New
2,900 $851,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Concentric Capital Strategies, LP Portfolio

Follow Concentric Capital Strategies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Capital Strategies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Capital Strategies, LP with notifications on news.